1. Иванец Н.Н., Анохина И.П., Винникова М.А., редакторы. Наркология: национальное руководство. 2-е издание, переработанное и дополненное. М.: ГЭОТАР-Медиа. 2016; 944 с.

2. Koob G.F. The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction. 2006; 101 (Supp 1): 23 - 30.

3. Соловьев А.Г., Вязьмин А.М., Мордовский Э.А. Методологические подходы к учету алкоголь-атрибутивной смертности в России и за рубежом. Обзоры по клинической фармакологии и лекарственной терапии. 2012; 4(10): 30 - 41.

4. Global status report on alcohol and health - 2014 ed. URL: www.who.int World Health Organization 2014; 86 c. ISBN 978 92 4 069276 3 (PDF) Дата обращения: 28.02.2017

5. Киржанова В.В., Григорова Н.И., Киржанов В.Н., Сидорюк О.В. Основные показатели деятельности наркологической службы в Российской Федерации в 2014 - 2015 годах: статистический сборник. М.: НИИ наркологии - филиал ФГБУ "ФМИЦПН им. В.П. Сербского" Минздрава России. 2016; 177 с.

6. Киржанова В.В., Григорова Н.И., Киржанов В.Н., Сидорюк О.В. Основные показатели деятельности наркологической службы в Российской Федерации в 2015 - 2016 годах: Статистический сборник. М.: ФГБУ "ФМИЦПН им. В.П. Сербского" Минздрава России. 2017; 183 с.

7. Diagnostic and statistical manual of mental disorders. 5th ed. 2. Mental Disorders - classification. 3. Mental Disorders-diagnosis. WM 15. p. 481 - 590, 809 - 916. URL: https://www.psychiatry.org/psychiatrists/practice/dsm. Дата обращения: 10.09.2018.

8. Иванец Н.Н., Анохина И.П., Винникова М.А., редакторы. Алкоголизм. Руководство для врачей. М.: Медицинское информационное агентство. 2011; 856 с.

9. Иванец Н.Н., Винникова М.А. Психические и поведенческие расстройства вследствие злоупотребления психоактивными веществами. Рациональная фармакотерапия в психиатрической практике. Руководство для практикующих врачей. Под общей редакцией чл-корр. РАМН Ю.А. Александровского, проф. Н.Г. Незнанова. М.: Литттера. 2014; 582 - 692.

10. Гофман А.Г. Клиническая наркология. М.: Миклош. 2003; 215 с.

11. Standridge J.B., Adams S.M., Zotos A.P., Urine Drug Screening: A Valuable Office Procedure. Am. Fam. Physician.2010 Mar 1; 81(5): 635 - 640.

12. Alcoholism Workup. Laboratory Studies. URL: http://emedicine.medscape.com/article/285913-workup#c6 Дата обращения: 28.02.2017.

13. S., J.B., J., R.C., J.A. et al. Alcoholism: Common and Oxidative Damage Biomarkers. J Clin Toxicol 2014; S7: S7-006. doi: 10.4172/2161-0495.S7-006 URL: https://www.omicsonline.org/open-access/alcoholism-common-and-oxidative-damage-biomarkers-2161-0495.1000-S7-006.pdf Дата обращения: 28.02.2017.

14. O. Biomarkers in alcoholism. Clin. Chim. Acta. 2007 Feb; 377(1-2): 39 - 49.

15. Hannuksela M.L. Liisanantti M.K. Nissinen A.E. Savolainen M.J. Biochemical markers of alcoholism. Clin. Chem. Lab. Med. 2007; 45(8): 953 - 961.

16. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment. The role of biomarkers in the Treatment of Alcohol Use Disorders. US Department of Health and Human Services. September. 2006 URL:http://kap.samsha.gov/. Дата обращения: 28.02.2017.

17. Sommers M.S. Savage C., Wray J., Dyehouse J.M., Laboratory measures of alcohol (ethanol) consumption: strategies of assess drinking patterns with biochemical measures. Biol. Res. Nurs. 2003 Jun; 4(3): 203 - 207.

18. Hock B., Schwarz M., Domke I., Grunert V.P., Wuertemberger M., Schiemann U., Horster S., Limmer C., Stecker G., Soyka M. Validity of carbohydrate-deficient transferrin (CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction.2005 Oct; 100(10): 1477 - 1486. URL:https://www.ncbi.nlm.nih.gov/pubmed/16185209 Дата обращения: 10.09.2018.

19. Fuster D., Sanvisens A., Bolao F., Zuluaga P., Rivas I., Tor J., Muga R. Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore). 2015 Mar; 94(10): 607. doi: 10.1097/MD.0000000000000607. URL:https://www.ncbi.nlm.nih.gov/pubmed/25761182 Дата обращения: 10.09.2018.

20. Dastych M., J., Pokora J., B., H., E., J. [Article in Czech] Diagnostic value of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean erythrocyte volume as laboratory markers of chronic alcohol abuse. VnitrLek. 2003 Feb; 49(2): 115 - 20. URL:https://www.ncbi.nlm.nih.gov/pubmed/12728578 Дата обращения: 10.09.2018.

21. Anton R.F., Youngblood M. Factors affecting CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study./Alcoholism, clinical and experimental research. 2006; 30(11): 1878 - 1883. doi: https://doi.org/10.1111/j.1530-0277.2006.00225.xURL: https://www.cochranelibrary.com/search Дата обращения: 10.09.2018.

22. Schwan R., Albuisson E., Malet L., Loiseaux M.N., Reynaud M., Schellenberg F., Brousse G., Llorca P.M. The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend. 2004 Jun 11; 74(3): 273 - 279. URL:https://www.ncbi.nlm.nih.gov/pubmed/15194205 Дата обращения: 10.09.2018.

23. Sharpe P.C. Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem. 2001 Nov; 38(Pt6): 652 - 664. URL:https://www.ncbi.nlm.nih.gov/pubmed/11732647 Дата обращения: 10.09.2018.

24. Golka K., Wiese A. Carbohydrate-deficient transferrin (CDT) - a biomarker for long-term alcohol consumption. JToxicol Environ Health B Crit Rev. 2004 Jul - Aug; 7(4): 319 - 37. URL: https://www.ncbi.nlm.nih.gov/pubmed/15205047 Дата обращения: 10.09.2018.

25. Aithal G.P., Thornes H., Dwarakanath A.D., Tanner A.R. Measurement of carbohydrate-deficient transferrin (CDT) in a general medical clinic: Is this test useful in assessing alcohol consumption? Alcohol and Alcoholism. 1998; 33(3): 304 - 309.

26. Srisurapanont M., Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2005; 1: CD001867. URL:https://www.ncbi.nlm.nih.gov/pubmed/21154349. Дата обращения: 23.07.2018.

27. Opioid antagonists for alcohol dependence. Cochrane Systematic Review. URL: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001867.pub3/full?highlightAbstract=naltrexone&highlightAbstract=naltrexon Дата обращения: 10.09.2018.

28. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49: 876 - 880.

29. Volpicelli J.R., Watson N.T., King A.C., Sherman Ce., O'Brien C.P. Effect of naltrexon on alcohol "high" in alcoholics. Am J Psychiatry. 1995; 152(4): 613 - 615.

30. O'Malley S.S., Jaffe A.J., Chang G et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry. 1992 Nov; 49: 881 - 887.

31. Volpicelli J.R., Rhines K.S., Rhines J.S. et al. Naltrexone and alcohol dependence: role of subject compliance. J. Arch. Gen. Psychiatry. 1997 Aug; 54(8): 737 - 742.

32. Jaffe A.J., Rounsaville B., Chang G., Schottenfeld R.S., Meyer R.E., O'Malley S.S. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J. Consult Clin Psychol. 1996; 64: 1044 - 1053.

33. Винникова М.А. Лобачева А.С., Басманова Т.В., Бойко Е.О., Гуревич Г.П. Антаксон в терапии патологического влечения к алкоголю: результаты сравнительных исследований. Вопросы наркологии. 2007; 1: 5 - 11.

34. Dunbar J.D., Turncliff R.Z., Dong Q. et al. Single and multiple dose pharmacokinetics of long-acting naltrexone. Alcohol Clin Exp. Res. 2006; 30: 480 - 490.

35. Krupitsky E., Woody G.E., Zvartau E., O"Brien C.P. Addiction treatment in Russia. Lancet. 2010 Oct 2; 376 (9747): 1145. PubMed PMID: 20888988. Comment on: Lancet. 2010 Jul 3; 376(9734): 13 - 14.

36. Kranzler H.R., Song Liou et al. Effect of long-acting injectable Naltrexone on Quality of Life URL: http://www.biomedcentral.com/1471-244X/5/18 Дата обращения: 01.12.2017.

37. National Institute on Alcohol abuse and alcoholism. Helping Patients Who Drink Too Much: A Clinitian Guide. URL:https://www.niaaa.nih.gov/guide. Дата обращения: 01.12.2017.

38. Garbutt J.C., Kranzler H.R., O'Malley S.S. et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005; 293(13): 1617 - 1625.

39. Gastfriend D.R., Dong Q., Loewy J. et al. Durability of Effect of Long-Acting Injectable Naltrexone. URL:https://www.ncbi.nlm.nih.gov/pubmed/15811981. Дата обращения: 01.12.2017.

40. Gastfriend D.R., Dong Q., Loewy J. et al. Durability of effect of long-acting injectable naltrexone. Presented at: Annual Meeting of the American Psychiatric Association, 2005. Atlanta, GA.

41. Крупицкий Е.М. Различные стратегии применения налтрексона для лечения алкоголизма: краткий обзор результатов научных исследований. Новые лекарственные препараты. 2006; 2: 44 - 47.

42. Блохина Е.А., Крупицкий Е.М., Брюн Е.А. Опыт применения Вивитрола (налтрексона пролонгированного действия в инъекциях) в клинической практике для лечения алкогольной зависимости. Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2010; 3: 58 - 61.

43. Aubin H.J. Efficacy of Disulfiram revisited: systematic review and meta-analysis. Alcohol and alcoholism. Conference: 15th European society for biomedical research on alcoholism congress, ESBRA 2015. Spain, 2015, 50 (Supplement 1), i14 (added to CENTRAL: 30 April 2018 Issue 4). doi:https://doi.org/10.1093/alcalc/agv076.50. URL: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01468501/full?highlightAbstract=disulfiram. Дата обращения: 10.09.2018.

44. Kleber H.D., Weiss R.D., Anton R.F. Jr. et al. Work Group on Substance Use Disorders; American Psychiatric Association; Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders (2nd Edition). Am J Psychiatry. 2007; 164: 5 - 123.

45. Chick J., Gough K., Falkowski W., Kershaw P., Hore B., Mehta B., Ritson B., Ropner R., Torley D. Disulfiram treatment of alcoholism./British journal of psychiatry. 1992; 161: 84 - 89.

46. Fuller R., Roth H., Long S. Compliance with disulfiram treatment of alcoholism./Journal of chronic diseases. 1983; 36(2): 161 - 170.

47. Christensen J.K., P., Vaag U.H. Side effects after disulfiram. Comparison of disulfiram and placebo in a double-blind multicentre study. Acta psychiatricascandinavica, 1984; 69(4): 265 - 273.

48. Azrin N.H., Sissons R.W., Meyer R.J. et al. Alcoholism treatment by disulfiram and community reinforcement therapy. J BehavTher Exp Psychiat. 1982; 13: 105 - 112.

49. Кораблев М.В., Курбат Н.М., Евец М.А. Молекулярные основы механизма противоалкогольного действия тетурама. Журн. невропатологии и психиатрии. 1981; 2: 128 - 134.

50. Арана Дж., Розенбаум Дж. Фармакотерапия психических расстройств. Руководство по психофармакотерапии. М.: Бином; 2004. 415 с.

51. Brewer C. How effective is the standard dose of disulfiram? Br J Psychiatry. 1984; 144: 200 - 202.

52. Fuller R.K., Branchey L., Brightwell D.R. et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA. 1986; 25: 1449 - 1455.

53. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. URL: http://journals.sagepub.com/doi/full/10.1177/0269881112444324 Дата обращения: 01.12.2017

54. Steven H. Williams, Medications for Treating Alcohol Dependence. Am Fam Physician. 2005 Nov 1; 72(9): 1775 - 1780.

55. Johnsen J., Morland J. Depot preparations of disulfiram: experimental and clinical results. Acta PsychiatrScand 1992; 86: 27 - 30.

56. Johnsen J., Morland J. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcohol Clin Exp Res. 1991; 15(3): 532 - 536.

57. Wilson A, Blanchard R, Davidson W, et al. Disulfiram implantation: a dose response trial. J Clin Psychiatry. 1984; 45(6): 242 - 247.

58. Минко А.И., Линский И.В. Применение Дисульфирама (Эсперали) в наркологической практике: история и новые возможности. Здоровье Украины. 2007; 11(1): 46 - 47.

59. Brewer C., Robert J. Meyers, Johnsen J. Does Disulfiram Help to Prevent Relapse in Alcohol Abuse? CNS Drugs. 2000; 14(5): 329 - 341.

60. Richard K. Fuller Enoch Gordis. For Debate - Does disulfiram have a role in alcoholism treatment today? Addictions. January 2004; 99(1): 21 - 24. doi: 10.1111/j.1360-0443.2004.00597.x

61. JasonLuty. Какие методы наиболее эффективны в лечении расстройств, связанных с употреблением алкоголя? Advances in Psychiatric Treatment. 2006; 12: 13 - 22.

62. Soyka M. Relapse prevention in alcoholism, recent advances and future possibilities. CNS Drugs. 1997; 4: 313 - 327.

63. Валентик Ю.В., Новиков Е.М. Применение препарата Колме при лечении больных алкоголизмом. Наркология. 2002; 3: 2 - 4.

64. Иванец Н.Н., Кинкулькина М.А. Новые данные о сенсибилизирующей терапии алкогольной зависимости. Журнал неврологии и психиатрии им. С.С. Корсакова. 2004; 7: 43 - 48.

65. Иванец Н.Н., Винникова М.А., Козырева А.В. Результаты клинико-катамнестического сравнительного исследования препарата Колме в терапии алкогольной зависимости Вопросы наркологии. 2006; 2: 21 - 29.

66. Ajima M., Usuki K., Igarashi A., Okazaki R., Hamano, K., Urabe A. and Totsuka Y. Cyanamide-induced granulocytopenia. Internal Medicine. 1997; 36: 640 - 642.

67. Suzuki Y., Yokoyama A., Nakano M., Okuyama K., Takahash, H., Tamai H., Maruyama K. aIshii, H. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases. Alcoholism: Clinical and Experimental Research. 2000; 24: 100 - 105.

68. Винникова М.А., Мохначев С.О., Ненастьева А.Ю., Усманова Н.Н., Козырева А.В., Лобачева А.С., Русинова О.И., Жердева М.А., Пинская Н.В., Сивач Т.В. Терапевтическая эффективность и безопасность Цианамида в сравнении Дисульфирамом при лечении больных с зависимостью от алкоголя: сравнительное открытое рандомизированное мультицентровое клиническое исследование. Вопросы наркологии. 2013; 1: 46 - 64.

69. Tamai H., Yokoyama A., Okuyama K., Takahashi H., Maruyama K., Suzuki Y., Ishii H. Comparison of cyanamide and disulfiram in effects on liver function. Alcohol Clin Exp Res. 2000 Apr; 24 (4 Suppl): 97 - 99.

70. Niederhofer H., Staffen W., Mair A. Comparison of cyanamide and placebo in the treatment of alcohol dependence of adolescents. Alcohol and alcoholism. 2003; 38(1): 50 - 53.

71. Brewer C. Cyanamide or disulfiram in the treatment of adolescent alcohol misusers? Alcohol and Alcoholism. 2003 Sep - Oct; 38(5): 442.

72. J.P., Tillonen J.S., Kaihovaara P.S., Salaspuro M.P. Lack of disulfiram-like reaction with metronidazole and ethanol./Annals of pharmacotherapy. 2002; 36(6): 971 - 974. doi:https://doi.org/10.1345/aph.1A066.

73. Semer J.M., Friedland P., Vaisberg M., Greenberg A. The use of metronidazole in the treatment of alcoholism: a pilot study./Am J Psychiatry. 1966 Dec; 23(6): 722 - 724.

74. Иванец Н.Н. Место антидепрессантов в терапии патологического влечения к алкоголю. Сб. Антидепрессанты в терапии патологического влечения к психотропным веществам. М.: Политек-Ф; 2000. 8 - 16.

75. Крупицкий Е.М., Ериш С.М., Бернцев В.А., Киселев А.С., Александровский Н.А., Торбан М.Н., Ерошин С.П., Ерышев О.Ф. Двойное слепое рандомизированное плацебо-контролируемое исследование эффективности применения эсциталопрама для коррекции аффективных расстройств у больных алкогольной зависимостью в ремиссии. Вопросы наркологии. 2009; 6: 17 - 34.

76. Крупицкий Е.М., Ериш С.М., Рыбакова К.В., Киселев А.С., Бернцев В.А., Торбан М.Н., Ерошин С.П., Ерышев О.Ф. Простое слепое рандомизированное плацебо-контролируемое исследование эффективности применения тразодона для коррекции аффективных расстройств у больных с алкогольной зависимостью в ремиссии. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2012; 1: 29 - 37.

77. Krupitsky E.M., Yerish S.M., Kiselev A.S., Berntsev V.A., Alexandrovskyi N.A., Torban M.N., Eroshin S.P., Eryshev O.F. A double blind, placebo-controlled, randomized clinical trial of escitalopram for the treatment of affective disorders in alcohol depedent patients in eraly remission. Chapter 16. In: The international psychiatry and behavioral neuroscience yearbook, Vol. II/Eds: N. Boutros, T. Sumiyoshi, A. Javanbakht, E.M. Krupitsky. - New York: Nova Science Publisher; 2012. 239 - 256.

78. Ivanets N.N., Lavrinenko O.V., Maximova T.N. Treatment of depression complicated by abuse and dependence on alcohol. NevrolPsikhiatrIm S SKorsakova. 2017; 117(7): 53 - 58. doi: 10.17116/jnevro20171177153-58.

79. Альтшулер В.Б. Патологическое влечение к алкоголю: вопросы клиники и терапии. М.: Издат. дом "Имидж"; 1994. 216 с.

80. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Systematic Review. URL:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008581.pub2/full?highlightAbstract=alcohol&highlightAbstract=antidepress&highlightAbstract=antidepressants. Дата обращения 10.09.2018.

81. Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Systematic Review. URL:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007505.pub2/full?highlightAbstract=alcohol&highlightAbstract=antidepress&highlightAbstract=antidepressants. Дата обращения 10.09.2018.

82. Soyka M., Kranzler H.R., Hesselbrock V., Kasper S., Mutschler J., H.J. Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. URL:http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Guidelines_for_biological_treatment_of_substance_use_and_related_disorders Дата обращения: 13.07.2018.

83. Винникова М.А. Агибалова Т.В., Гуревич Г.Л., Мищенко Л.В. Использование ламиктала (ламотриджина) в терапии больных с алкогольной зависимостью: результаты сравнительного исследования. Психиатрия и психофармакотерапия. 2004; 5(6): 245 - 248.

84. Ivanets N., Vinnikova M., Agibalova T., Zhirov I. Normothymics in treatment of alcohol craving: results of a comparative study. European Neuropsychopharmacology. The Yournal of the European College of Neuropsychopharmacology. Abstracts of the 8th ECNP Regional Meeting; 2005 April 14 - 16. 274.

85. Anticonvulsants for alcohol dependence. Cochrane Systematic Review. URL:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008544.pub2/full?highlightAbstract=alcohol&highlightAbstract=antidepress&highlightAbstract=antidepressants. Дата обращения 10.09.2018.

86. Anton R.F., Kranzler H., Breder C. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol. 2008; 28: 5 - 12.

87. Martinotti G., Di Nicola M., Di Giannantonio M., Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. J Psychopharmacol. 2009; 23: 123 - 129.

88. Иванец Н.Н., Винникова М.А. Рисполепт (рисперидон) в терапии алкогольной зависимости. Вопросы наркологии. 2003; 2: 4 - 12.

89. Дмитриева Т.Б., Игонин А.Л., Клименко Т.В. и др. Злоупотребление психоактивными веществами (общая и судебно-психиатрическая практика). Москва: ГНЦ СиСП им. В.П. Сербского; 2000. 300 с.

90. Альтшулер В.Б. Соотношение биологического и социального в болезненном влечении к алкоголю и терапия алкоголизма нейролептиками. Сб.: Патогенез, клиника и лечение алкоголизма; 1976. 68 - 71.

91. Агибалова Т.В., Шустов Д.И., Тучина О.Д. Введение в психотерапию в наркологии, применение научно-доказательных моделей психотерапевтического воздействия. Оценка эффективности психотерапии. В кн.: Н.Н. Иванец, И.П. Анохина, М.А. Винникова. Национальное руководство по наркологии. М.: ГЭОТАР-Медиа, 2016; Глава 10; С. 688 - 699.

92. Назыров Р.К., Ремесло М.Б., Ляшковская С.В. и др. Типология психотерапевтических мишеней и ее использование для повышения качества индивидуальных психотерапевтических программ в лечении больных с невротическими расстройствами. СПб.: СПб НИПНИ им. В.М. Бехтерева, 2014; 19 с.

93. Norcross J.C., Lambert M.J. Evidence-based therapy relationships. In: J.C. Norcross. Psychotherapy relationships that work: Evidence-based responsiveness. New York: Oxford University Press, 2011; 3 - 24.

94. Smedslund G., Berg R.C., K.T., et al. Motivational interviewing for substance abuse. CochraneDatabaseSystRev. 2011; CD008063.

95. Magill M., Ray L.A. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009; N 70 (4): 516 - 27.

96. Агибалова Т.В., Шустов Д.И., Кошкина Е.А., Тучина О.Д. Психотерапия в наркологии - обзор научно-доказательных моделей психотерапевтического вмешательства: зарубежный опыт. Часть 1. Психотерапия как эмпирически обоснованный метод лечения. Вопросы наркологии. 2015; N 2: С. 69 - 81.

97. Агибалова Т.В., Шустов Д.И., Тучина О.Д., Тучин П.В. Психотерапия в наркологии - обзор научно-доказательных моделей психотерапевтического вмешательства: зарубежный опыт. Часть 2. Эмпирически обоснованные методы психотерапии наркологических заболеваний. Вопросы наркологии. 2015; N 5: С. 46 - 65.

98. Tai B., Straus M.M., Liu S.D. et al. The first decade of the national drug abuse treatment clinical trials network: bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment. 2010. N 38 (Suppl. 1): 4 - 13.

99. Glasner-Edwards S., Rawson R. Evidence-based practices in addiction treatment: review and recommendations for public policy. Health Policy. 2010. N 97 (2 - 3): 93 - 104.

100. National Institute on Drug Abuse. Principles of drug addiction treatment: a research-based guide. NIH, 2012; 176 p.

101. Newton-Howes G.M., Foulds J.A., Guy N.H., Boden J.M., Mulder R.T. Personality disorder and alcohol treatment outcome: systematic reviewandmeta-analysis. Br J Psychiatry. 2017; N 211(1): 22 - 30.

102. Morin J., Harris M., Conrod P. A review of CBT treatments for Substance Use Disorders. Oxford Handbooks Online. 2017; URL: http: www.oxfordhandbooks.com. view. 10.1093. oxfordhb. 9780199935291.001.0001. oxfordhb-9780199935291-e-57.

103. McGovern M.P., Carroll K.M. Evidence-based practices for substance use disorders. Psychiatr Clin North Am. 2003; N 26(4): 991 - 1010.

104. Carroll K.M., Kiluk B.D. Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again. Psychol Addict Behav. 2017; N 31 (8): 847 - 861.

105. Dutra L, Stathopolou G, Basden S, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008; N 165: 179 - 87.

106. Conrod P.J. Personality-Targeted Interventions for Substance Use and Misuse. Current Addiction Reports. 2016; N 3(4): 426 - 36.

107. Kramer Schmidt L., Bojesen A.B., Nielsen A.S., Andersen K. Duration of therapy - Does it matter?: Asystematic review and meta-regression of the duration of psychosocial treatments for alcohol use disorder. J Subst Abuse Treat. 2018; N 84: 57 - 67.

108. Foulds J., Newton-Howes G., Guy N., Boden J.M., Mulder R.T. Dimensional personality traits and alcohol treatment outcome: a systematic review and meta-analysis. Addiction. 2017; N 112 (8): 1345 - 1357.

109. Hershberger A.R., Um M., Cyders M.A. The relationship between the UPPS-P impulsive personality traits and substance use psychotherapy outcomes: A meta-analysis. DrugAlcoholDepend. 2017; N 178: 408 - 416.

110. Dieperink E., Fuller B., Isenhart C., McMaken K., Lenox R., Pocha C., Thuras P., Hauser P. Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial. Addiction. 2014; N 109: 1869 - 1877.

111. Lundahl B.W., Kunz C., Brownell C., Tollefson D., Burke B.L. A meta-analysis of motivational interviewing: twenty-five years of empirical studies. Research on Social Work Practice. 2010; N 20(2): 137 - 160.

112. Reid S.C., Teesson M., Sannibale C., Matsuda M., Haber P.S. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial. Journal of Studies on Alcohol. 2005; N 66(6): 833 - 41.

113. Bauer S., Strik W., Moggi F. Motivation as a predictor of drinking outcomes after residential treatment programs for alcohol dependence. J Addict Med. 2014; N 8(2): 137 - 42.

114. Lenz A.S., Rosenbaum L., Sheperis D. Meta-Analysis of Randomized Controlled Trials of Motivational Enhancement Therapy for Reducing Substance Use. Journal of Addictions & Offender Counseling. 2016; N 37(2): 66 - 86.

115. Kelly J.F., Magill M., Stout R.L. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. AddictionResearch&Theory. 2009; N 17(3): 236 - 59.

116. Small J., Ounpraseuth S., Curran G.M., Booth B.M. Motivation to change as a mediator for the longitudinal relationships of gender and alcohol severity with one-year drinking outcome. Journal of Studies on Alcohol and Drugs. 2012; N 73: 504 - 513.

117. Magill M., Kiluk B.D., McCrady B.S., Tonigan J.S., Longabaugh R. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin Exp Res. 2015; N 39 (10): 1852 - 62.

118. Sellman J.D., Sullivan P.F., Dore G.M., Adamson S.J., MacEwan I. A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. Journal of Studies on Alcohol. 2001; N 62(3): 389 - 96.

119. O'Farrell T.J., Allen J.P., Litten R.Z. Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA ResMonogr. 1995; N 150: 65 - 91.

120. Агибалова Т.В., Шустов Д.И., Тучина О.Д., Мухин А.А., Гуревич Г.Л. Стратегия снижения потребления алкоголя как новая возможность в терапии алкогольной зависимости. Социальная и клиническая психиатрия. 2015; N 25 (3): С. 61 - 68.

121. Агибалова Т.В., Бузик О.Ж., Голощапов И.В., Рычкова О.В. Согласие на лечение в наркологии: старая проблема и новый подход. Наркология. 2008; N 1: С. 91 - 95.

122. Jarosz J., Miernik K., Wachal M., Walczak J., Krumpl G. Naltrexone (50 mg) plus psychotherapyinalcohol-dependent patients: a meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2013; N 39(3): 144 - 60.

123. Simpson D.D., Flynn P.M. Drug Abuse Treatment Outcome Studies (DATOS): a national evaluation of treatment effectiveness. In: Fisher G., Roget N. Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery. ThousandOaks (CA): SagePublishing, 2008; 303 - 7.

124. Svanberg J., Evans J. J. Neuropsychological rehabilitation in alcohol-related brain damage: a systematic review. Alcohol and Alcoholism. 2013; N 48: 704 - 711.

125. Bates M.E., Buckman J.F., Nguyen T.T. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders

126. Oudman E., Nijboer T. C. W., Postma A., et al. Acquisition of an instrumental activity of daily living in patients with Korsakoff's syndrome: A comparison of trial and error and errorless learning. Neuropsychological Rehabilitation. 2013; N 23: 888 - 913.

127. Nandrino J.-L., Gandolphe M.-C., El Haj M. Autobiographical memory compromise in individuals with alcohol use disorders: Towards implications for psychotherapy research. Drug and Alcohol Dependence. 2017; N 179: 61 - 70.

128. Fals-Stewart W., Lucente S. The effect of cognitive rehabilitation on the neuropsychological status of patients in drug abuse treatment who display neurocognitive impairment. Cognit Rehabil. 1994; N 39: 75 - 94.

129. Bickel W., Jarmolowicz D.P., Mueller E.T., Koffarnus M.N., Gatchalian K.M. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: Emerging evidence. Pharmacology & Therapeutics. 2012; N 134 (3): 287 - 97.

130. Hien D.A., Wells E.A., Jiang H., et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009; N 77: 607 - 619.

131. Rezapour T., Hatami J., Farhoudian A., et al. NEuroCOgnitiveREhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial. Basic Clin Neurosci. 2015; N 6(4): 291 - 8.

132. Houben K., Wiers R.W., Jansen A. Getting a grip on drinking behavior: training working memory to reduce alcohol abuse. Psychol. Sci. 2011; N 22 (7): 968 - 75.

133. Тучина О.Д., Шустов Д.И., Новиков С.А., Тучин П.В. Память будущего: обзор исследований проспективного мышления у пациентов с синдромом зависимости от алкоголя. Вопросы наркологии. 2017; N 12. С. 145 - 177.

134. Grant S., Colaiaco B., Motala A., et al. Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis. Addict Med. 2017; N 11(5): 386 - 396.

135. Irvin J.E., Bowers C.A., Dunn M.E., Wang M.C. Efficacy of relapse prevention: A meta-analytic review. J Consult Clin Psychol. 1999; N 67: 563 - 570.

136. Brown R.A., Ramsey S.E., Kahler C.W., et al. A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. J Stud Alcohol Drugs. 2011; N 72(2): 286 - 296.

137. Valentine S.E., Bankoff S.M., Poulin R.M. et al. The use of dialectical behavior therapy skills training as stand-alone treatment: a systematic review of the treatment outcome literature. J Clin Psychol. 2015; N 71(1): 1 - 20.

138. Агибалова Т.В., Рычкова О.В., Вальчук Д.С., и др. Психотерапевтическая программа по снижению патологического влечения к алкоголю: предварительная оценка эффективности. Вопросы наркологии. 2016; N 7 - 8: С. 34 - 43.

139. Шустов Д.И., Тучина О.Д. Психотерапия алкогольной зависимости. СПб.: СпецЛит, 2016; 416 с.

140. Berking M., Margraf M., Ebert D., et al. Deficits in emotion-regulation skills predict alcohol use during and after cognitive-behavioral therapy for alcohol dependence. J Consult Clin Psychol. 2011; N 79(3): 307 - 18.

141. Tang Y.Y., Tang R., Posner M.I. Mindfulness meditation improves emotion regulation and reduces drug abuse. Drug Alcohol Depend. 2016; N 163 (Suppl 1): 13 - 8.

142. Grow J.C., Collins S.E., Harrop E.N., Marlatt G.A. Enactment of home practice following mindfulness-based relapse prevention and its association with substance-use outcomes. Addictive Behaviors. 2015; N 40: 16 - 20.

143. Carroll K.M., Onken L.S. Behavioral therapies for drug abuse. Am J Psychiatry. 2005; N 162: 1452 - 60.

144. Bowen S., Witkiewitz K., Clifasefi S.L., et al. Relative efficacy of mindfulness based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry. 2014; N 71 (5): 547 - 556.

145. Sancho M., De Gracia M., R.C., et al. Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review. Frontiers in Psychiatry. 2018; 9. URL:http://dx.doi.org/10.3389/fpsyt.2018.00095

146. Naqvi N.H., Ochsner K.N., Kober H., et al. Cognitive regulation of craving in alcohol-dependent and social drinkers. Alcohol Clin Exp Res. 2015; N 39(2): 343 - 9.

147. Jones A., Di Lemma L.C., Robinson E., et al. Inhibitory control trainingforappetitive behaviour change: A meta-analytic investigation of mechanisms of action and moderators of effectiveness. Appetite. 2016; N 97: 16 - 28.

148. Coates J.M., Gullo M.J., Feeney G.F.X., Young R.M., Connor J.P. A Randomized Trial of Personalized Cognitive-Behavior Therapy for Alcohol Use Disorder in a Public Health Clinic. Frontiers in Psychiatry. 2018; N 9. URL: http://dx.doi.org/10.3389/fpsyt.2018.00297

149. Hester R.K., Delaney H.D., Campbell W., Handmaker N. A web application for moderation training: Initial results of a randomized clinical trial. Journal of Substance Abuse Treatment. 2009; N 37: 266 - 276.

150. Miller W.R., Leckman A.L., Delaney H.D., Tinkcom M. Long-term follow-up of behavioral self-control training. J Stud Alcohol. 1992; N 53(3): 249 - 61.

151. O'Farrell T.J., Choquette K.A., Cutter H.S., et al. Behavioral marital therapy with and without additional couples relapse prevention sessions for alcoholics and their wives. Journal of Studies on Alcohol. 1993; N 54(6): 652 - 666.

152. McCrady B.S., Epstein E.E., Cook S., Jensen N., Hildebrandt T. A randomized trial of individual and couple behavioral alcohol treatment for women. J Consult Clin Psychol. 2009; N 77(2): 243 - 256.

153. O'Farrell T.J. Review of outcome research on marital and family therapy in treatment of alcoholism. Journal of Marital and Family Therapy. 2012; N 38(1): 122 - 144.

154. Klostermann K., Kelley M.L., Mignone T., Pusateri L., Wills K. Behavioral couples therapy for substance abusers: where do we go from here? Subst Use Misuse. 2011; N 46(12): 1502 - 9.

155. Giusto A., Puffer E. A systematic review of interventions targeting men"s alcohol use and family relationships in low- and middle-income countries. Glob Ment Health (Camb). 2018; N 5: e10. URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885490/

156. Агибалова Т.В., Бузик О.Ж., Эм Т.В. Психотерапия психопатологических расстройств у матерей и жен, сыновья и мужья которых страдают алкогольной зависимостью. Вопросы наркологии. 2016; N 11 - 12: С. 71 - 85.

157. Schumm J.A., O"Farrell T.J., Kahler C.W., Murphy M.M., Muchowski P. A randomized clinical trial of behavioralcouples therapy versus individually based treatment for women with alcohol dependence. J Consult Clin Psychol. 2014; N 82(6): 993 - 1004.

158. Vedel, E., Emmelkamp, P. M. G., & Schippers, G. M. Individual cognitive-behavioral therapy and behavioralcouples therapy in alcohol use disorder: A comparative evaluation in community-based addiction treatment centers. Psychotherapy and Psychosomatics, 2008; N 77(5): 280 - 288.

159. Henderson C.E., Dakof G.A., Greenbaum P.E., Liddle H.A. Effectivenessofmultidimensional family therapy with higher severity substance-abusing adolescents: report from two randomized controlled trials. J Consult Clin Psychol. 2010; N 78(6): 885 - 97.

160. Slesnick N., Zhang J. Family systems therapyforsubstance-using mothersandtheir 8- to 16-year-old children. Psychol Addict Behav. 2016; N 30(6): 619 - 29.

161. Del Re A.C., Fluckiger C., Horvath A.O. et al. Therapist effects in the therapeutic alliance-outcome relationship: a restricted-maximum likelihood meta-analysis. Clin Psychol Rev 2012; N 32: 642 - 9.

162. Norcross J.C., Lambert M.J. Psychotherapy relationships that work II. Psychotherapy. 2011; N 48(1): 4 - 8.

163. Imel Z.E., Wampold B.E., Miller S.D., Fleming R.R. Distinctions without a difference: direct comparisons of psychotherapies for alcohol use disorders. Psychol Addict Behav. 2008; N 22(4): 533 - 43.

164. Meier P.S., Donmall M.C., McElduff P., et al. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence. 2006; N 83(1): 57 - 64.

165. , C., Del Re, A. C., Wampold, B. E., & Horvath, A. O. The alliance in adult psychotherapy: A meta-analytic synthesis. Psychotherapy, 2018; N 55(4): 316 - 340.

166. Cook S., Heather N., McCambridge J. The role of the working alliance in treatment for alcohol problems. Psychol Addict Behav. 2015; N 29(2): 371 - 81.

167. Richardson D.F., Adamson S.J., Deering D.E.A. The role of therapeutic alliance in treatment for people with mild to moderate alcohol dependence. International Journal of Mental Health and Addiction. 2011; N 10(5): 597 - 606.

168. Moyers T.B., Miller W.R. Is low therapist empathy toxic? Psychol Addict Behav. 2013; N 27 (3): 878 - 884.

169. Moyers T.B., Houck J., Rice S.L., Longabaugh R., Miller W.R. Therapist empathy, combined behavioral intervention, and alcohol outcomes in the COMBINE research project. Journal of Consulting and Clinical Psychology. 2016; N 84(3): 221 - 9.

170. White W.L., Miller W.R. The use of confrontation in addiction treatment: History, science, and time for a change. The Counselor. 2007; N 8 (4): 12 - 30.

171. Miller W.R., Benefield R.G., Tonigan J.S. Enhancing motivation for change in problem drinking: A controlled comparison of two therapist styles. Journal of Consulting and Clinical Psychology. 1993; N 61: 455 - 461.

172. Saarnio P. Factors associated with dropping out from outpatient treatment of alcohol-other drug abuse. Alcoholism Treatment Quarterly. 2002; N 20(2): 17 - 33.

173. Morgenstern J., Kuerbis A., Amrhein P., et al. Motivational interviewing: a pilot test of active ingredients and mechanisms of change. Psychol Addict Behav. 2012; N 26(4): 859 - 869.

174. Dundon W.D., Pettinati H.M., Lynch K.G., et al. The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence. Drug Alcohol Depend. 2008; N 95(3): 230 - 236.

175. Karno M.P., Longabaugh R. An examination of how therapist directiveness interacts with patient anger and reactance to predict alcohol use. Journal of Studies on Alcohol. 2005; N 66: 825 - 832.

176. Urbanoski K.A., Kelly J.F., Hoeppner B.B., Slaymaker V. The role of therapeutic alliance in substance use disorder treatment for young adults. J Subst Abuse Treat. 2012; N 43(3): 344 - 51.

177. Kaner E.F., Dickinson H.O., Beyer F., et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev. 2009; N 28: 301 - 323.

178. Schmidt C.S., Schulte B., Seo H.N., et al. Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction. 2016; N 111: 783 - 94.

179. Pettinati H.M., Volpicelli J.R., Pierce J.D., Jr, et al. Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J AddictDis. 2000; N 19: 71 - 83.

180. Tanner-Smith E.E., Risser M.D. A meta-analysis of brief alcohol interventions for adolescents and young adults: variability in effects across alcohol measures. Am J Drug Alcohol Abuse. 2016; N 42(2): 140 - 151.

181. Klimas J., Tobin H., Field C.A., et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database of Systematic Reviews. 2014; Issue 12., Art. No.: CD009269.

182. DiClemente C. C., Soderstrom, C. Intervening with alcohol problems in emergency settings. In: D. W. Hungerford & D. A. Pollock. Alcohol problems among emergency department patients: Proceedings of a research conference on identification and intervention. 2002: P. 89 - 131.

183. Saitz R. Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev. 2010; N 29: 631 - 40.

184. Ball S.A., Martino S., Nich C., et al. Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol. 2007; N 75: 556 - 67.

185. Witkiewitz K., Hartzler B., Donovan D. Matching motivation enhancement treatment to client motivation: re-examining the Project MATCH motivation matching hypothesis. Addiction. 2010; N 105(8): 1403 - 13.

186. Lundahl B., Burke B.L. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol. 2009; N 65: 1232 - 45.

187. Sayegh C.S., Huey S.J., Zara E.J., Jhaveri K. Follow-up treatment effects of contingency management and motivational interviewing on substance use: A meta-analysis. Psychol Addict Behav. 2017; N 31: 403 - 414.

188. Riper H., Andersson G., Hunter S.B., de Wit J., Berking M., Cuijpers P. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction. 2014; N 109(3): 394 - 406.

189. Baker A., Bucci, S., Lewin T. J., et al. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders. British Journal of Psychiatry. 2006; N 188: 439 - 448.

190. Barrowclough C., Haddock G., Tarrier N., et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001; N 158: 1706 - 13.

191. Windsor L.C., Jemal A., Alessi E.J. Cognitive behavioral therapy: a meta-analysis of race and substance use outcomes. Cultur Divers Ethnic Minor Psychol. 2014; N 21(2): 300 - 313.

192. Benishek L.A., Dugosh K.L., Kirby K.C., et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014; N 109: 1426 - 36.

193. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol. 2000; N 68: 250 - 7.

194. McDonell M.G., Leickly E., McPherson S., et al. A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. Am J Psychiatry. 2017; N 174: 370 - 377.

195. Barnett N.P., Celio M.A., Tidey J.W., et al. A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor. Addiction. 2017; N 112: 1025 - 1035.

196. Linehan M.M., et al. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions. 1999; N 8(4): 279 - 292.

197. Lee N.K., Cameron J., Jenner L. A systematic review of interventions for co-occurring substance use and borderline personality disorders. Drug Alcohol Rev. 2015; N 34(6): 663 - 72.

198. Dimeff L.A., Linehan M.M. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008; N 4(2): 47 - 9.

199. Валентик Ю.В. Континуальная терапия. Московский психотерапевтический журнал. 1999; N 1: С. 47 - 58.

200. Валентик Ю.В., Булатников А.Н. Континуальный подход к психотерапии больных алкоголизмом. Вопр. наркологии. 1994; N 3: С. 8 - 12.

201. Валентик Ю.В. Континуальная психотерапия больных алкогольной зависимостью: автореф. дис. ... д-ра мед. наук. М., 1993; 70 с.

202. Шустов Д.И. Аутоагрессия и самоубийство при алкогольной зависимости: клиника и психотерапия. СПб: Спецлит, 2016; 207 с.

203. Шустов Д.И., Новиков С.А., Тучин П.В. Психотерапия алкогольной зависимости в классическом и современном трансакционном анализе. Российский психотерапевтический журнал. СПб, 2012; N 3-4 (4-5): С. 47 - 57.

204. Forghani M., Abadi B.H. The Effect of group therapy with transactional analysis approach on emotional intelligence, executive functions and drug dependency. Iranian Journal Of Psychiatry & Behavioral Sciences. 2016; N 10(2): 1 - 6.

205. Noce J.S., Noce S.F., McClellan A.T. The parenting function of therapeutic communities: Test of a model in an alcohol rehabilitation program. Transactional Analysis Journal. 1981; N 11: 236 - 240.

206. Olson R.P., Ganley R., Devine V.T., Dorsey G.C. Long-term effects of behavioral versus insight-oriented therapy with inpatient alcoholics. Journal of Consulting and Clinical Psychology. 1981; N 48: 866 - 877.

207. Shustov D.I., Tuchina O.D., Novikov S. Fedotov I. Combinations of injunctions and personality types determining forms of self-destructive behavior in alcohol-dependent clients: findings of a russian observational study. IJTAR (International Journal of Transactional Analysis Research). 2016; N 7(2): 10 - 20.

208. Knekt P., Laaksonen M.A., Raitasalo R., Haaramo P., Lindfors O. Changes in lifestyle for psychiatric patients three years after the start of short- and long-term psychodynamic psychotherapy and solution-focused therapy. European Psychiatry. 2010; N 25: 1 - 7.

209. Leichsenring F. Are psychodynamic and psychoanalytic therapies effective? International Journal of Psychoanalysis. 2005; N 86: 841 - 868.

210. Gregory R.J., Chlebowski S., Kang D., et al. A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychotherapy, 2008; N 45: 28 - 41.

211. Ferri M., Amato L., Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews. 2006, Issue 3. Art. No.: CD005032.

212. Kaskutas L.A. Alcoholics anonymous effectiveness: faith meets science. J Addict Dis. 2009; N 28(2): 145 - 57.

213. Vanderplasschen W., Vandevelde S., Broekaert E. Therapeutic communities for treating addictions in Europe: Evidence, current practices and future challenges. Luxembourg, 2014; 92 p.

214. Gossop M., Stewart D., Marsden J. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. Addiction. 2008; N 103: 119 - 25.

215. De Leon G., Sacks S., Staines G., McKendrick K. Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. American Journal of Drug and Alcohol Abuse. 2000; N 26: 461 - 480.

216. Pearson F.S., Prendergast M.L., Podus D. et al. Meta-analyses of seven of the National Institute on Drug Abuse"s principles of drug addiction treatment. Journal of Substance Abuse Treatment, 2012; N 43 (1): 1 - 11.

217. Bell M.D., Vissicchio N.A., Weinstein A.J. Cognitive training and work therapy for the treatment of verbal learning and memory deficits in veterans with alcohol use disorders. J Dual Diagn. 2016; N 12(1): 83 - 9.

218. Carr W.A., Ball S.A. Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents. J Subst Abuse Treat. 2014; N 46(5): 567 - 73.

219. Carroll K.M. Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry. 2004; N 56(10): 778 - 84.

220. Cakmak S., Sut H., Ozturk S., Tamam L., Bal U. The effects of occupational therapy and psychosocial interventions on interpersonal functioning and personal and social performance levels of corresponding patients. Noro Psikiyatri Arsivi [Internet]. Turk Noropsikiyatri Dernegi. 2016; N 53(3): 234 - 40.

221. Davis A., Marlow A. Occupational Therapy: Implications for substance abuse recovery and the criminal justice system. Innovative Practice Projects. 2014; Paper 54. URL: http://commons.pacificu.edu/ipp/54

222. Hohmann L., Bradt J., Stegemann T., Koelsch S. Effects of music therapy and music-based interventions in the treatment of substance use disorders: A systematic review. PLoS One.2017; N 12(11): e0187363. URL: doi: 10.1371/journal.pone.0187363.

223. United Nations. Drug abuse treatment and rehabilitation: a practical planning and implementation guide. Vienna, United Nations Office on Drugs and Crime, 2003; 143 p.

224. Валентик Ю.В., Сирота Н.А. Руководство по реабилитации больных с зависимостью от психоактивных веществ. М., 2002; 256 с.

225. Валентик Ю.В., Зыков О.В., Цетлин М.Г. Теория и практика медико-социальной работы в наркологии. М., 1997.

226. Дудко Т.Н. Концепции, принципы, технологии, методология, условия, порядок оказания реабилитационной помощи. В кн.: Н.Н. Иванец, И.П. Анохина, М.А. Винникова. Наркология: национальное руководство. М.: ГЭОТАР-Медиа, 2016; С. 774 - 787.

227. Брюн Е.А., Савченко Л.М., Соборникова Е.А. Опыт реабилитационной работы в системе помощи лицам, злоупотребляющим психоактивными веществами. Российский медицинский журнал. 2013; N 4: С. 45 - 49.

228. Агибалова Т.В., Тучин П.В., Тучина О.Д. Клинические рекомендации по медицинской реабилитации больных наркологического профиля: психотерапия в программах медицинской реабилитации. Вопросы наркологии. 2015; N 3: С. 87 - 107.

229. Hagen E., Erga A.H., Hagen K.P., et al. Assessment of executive function in patients with substance use disorder: a comparison of inventory- and performance-based assessment. J Subst Abuse Treat. 2016; N 66: 1 - 8.

230. Катков А.Л., Пак Т.В., Россинский Ю.А. Интегративно-развивающая групповая психотерапия зависимых от психоактивных веществ. Психотерапия, 2003; N 12: С. 15 - 24.

231. Kopelman M.D., Thomson A., Guerrini I., Marshall E.J. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol & Alcoholism. 2009; N 44: 148 - 154.

232. Брюн Е.А., Москвичев В.Г., Духанина И.В. Реабилитационно-профилактические технологии наркологической помощи. Здравоохранение Российской Федерации, 2007; N 4: С. 16 - 19.

233. Брюн Е.А. Совершенствование технологий управления профилактической и лечебно-реабилитационной наркологической помощью: Дис. ... д-ра мед. наук. М.; 2007.

234. Дудко Т.Н. Медико-социальная реабилитация больных наркоманией: Дис. ... д-ра мед. наук. М.; 2003.

235. Дудко Т.Н. Система основных принципов построения лечебно-реабилитационного процесса в наркологии. Вопросы наркологии. 1999; N 2: С. 28 - 34.

236. Winters K.C., Botzet A., Fahnhorst T. Advances in adolescent substance abuse treatment. Curr Psychiatry Rep. 2011; N 13(5): 416 - 21.

237. Krampe H., Stawicki S., Hoehe M.R., Ehrenreich H. Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism. Dialogues Clin Neurosci. 2007; N 9(4): 399 - 412.

238. Witkiewitz K., Hartzler B., Donovan D. Matching motivation enhancement treatment to client motivation: re-examining the Project MATCH motivation matching hypothesis. Addiction. 2010; N 105(8): 1403 - 13.

239. Daughters S.B., Magidson J.F., Anand D., et al. The effectof a behavioral activation treatment for substance useonpost-treatment abstinence: a randomized controlled trial. Addiction. 2017; URL: https: www.ncbi.nlm.nih.gov. pubmed. 28963853.

240. Smith M.A., Lynch W.J. Exercise as a potential treatment for drug abuse: evidence from preclinical studies. Front Psychiatry. 2012; N 2 (82). URL: https: www.ncbi.nlm.nih.gov. pmc. articles. PMC3276339.

241. Moos R.H. Theory-based active ingredients of effective treatmentsfor substance use disorders. Drug Alcohol Depend. 2007; N 88 (2-3): 109 - 21.

242. Дудко Т.Н. Концепции, принципы, технологии, методология, условия, порядок оказания реабилитационной помощи. В кн.: Н.Н. Иванец, И.П. Анохина, М.А. Винникова. Наркология: национальное руководство. М.: ГЭОТАР-Медиа, 2016; С. 774 - 787.

243. Дудко Т.Н. Уровни реабилитационного потенциала наркологических больных как основа дифференцированной системы их медико-социальной реабилитации. Вопросы наркологии. 2000; N 3: С. 13 - 21.

244. United Nations. TREATNET Quality standards for drug dependence treatment and care services. New York: UNITED NATIONS, 2012; 60 p.

245. Tai B., Volkow N.D. Treatment for substance use disorder: opportunities and challenges under the affordable care act. Soc Work Public Health. 2013; N 28 (3-4): 165 - 174.

246. Валентик Ю.В. Континуальная психотерапия больных с зависимостью от психоактивных веществ. В кн.: Н.Н. Иванец. Лекции по наркологии. М.: Нолидж, 2000; С. 341 - 364.

247. Агибалова Т.В., Тучин П.В., Тучина О.Д. Психотерапия в реабилитации наркологических больных. В кн. Национальное руководство по наркологии. М.: ГЭОТАР-Медиа, 2016. Глава 10: С. 740 - 743.

248. Powers M.B., Vedel E., Emmelkamp P.M.G. Behavioral couples therapy (BCT) for alcohol and drug use disorders: A metaanalysis. Clinical Psychology Review. 2008; N 28(6): 952 - 962.

249. Fals-Stewart W, Clinton-Sherrod M. Treating intimate partner violence among substance-abusing dyads: The effect of couples therapy. Professional Psychology: Research and Practice. 2009; N 40(3): 257 - 263.

250. Kraanen F.L., Vedel E., Scholing A., Emmelkamp P.M. The comparative effectiveness of Integrated treatment for Substance abuse and Partner violence (I-StoP) and substance abuse treatment alone: a randomized controlled trial. BMC Psychiatry. 2013; N 13:189. URL: http://journals.sagepub.com/doi/abs/10.1177/0886260515586369

251. Klostermann K., Kelley M.L., Mignone T., Pusateri L., Wills K. Behavioral couples therapy for substance abusers: where do we go from here? Subst Use Misuse. 2011; N 46(12): 1502 - 9.

252. Меринов А.В., Д.И. Шустов Психологические и суицидологические особенности женщин, состоящих в браке с мужчинами, страдающими алкогольной зависимостью и имеющие суицидальные наклонности. Журнал невропатологии и психиатрии им. С.С. Корсакова. 2011; N 111(2): С. 58 - 61.

253. Fals-Stewart W., Birchler G.R., Kelley M.L. Learning sobriety together: a randomized clinical trial examining behavioral couple's therapy with alcoholic female patients. Journal of Consulting and Clinical Psychology. 2006; N 74(3): 579 - 591.

254. Fals-Stewart W., Klosterman K., Yates B.T., O'Farrell T.J., Birchler G.R. Brief relationship therapy for alcoholism: A randomized clinical trial examining clinical efficacy and cost-effectiveness. Psychology of Addictive Behaviors. 2005; N 19(4): 363 - 371.

255. Smith J.E., Meyers R.J., Austin J.L. Working with family members to engage treatment-refusing drinkers: The CRAFT program. Alcoholism Treatment Quarterly. 2008; N 26: 169 - 193.

256. Koffarnus M.N., Wong C.J., Diemer K., et al. A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults. Alcohol Alcohol. 2011; N 46(5): 561 - 9.

257. Wang D., Wang Y., Wang Y., Li R., Zhou C.Impact of physical exercise on substance use disorders: a meta-analysis. PLoS One. 2014; N 9(10): e110728. URL: doi: 10.1371. journal.pone.0110728. eCollection 2014.

258. Энтин Г.М. Летальные исходы при нарушениях режима трезвости после опосредованной стресс-психотерапии больных алкоголизмом. Социальная и клиническая психиатрия. 2001; N 4: С. 88 - 89.

259. Энтин Г.М., Копоров С.Г. Алкогольная ситуация в России и эффективность опосредованной стресс-психотерапии при лечении больных синдромом алкогольной зависимости. Наркология. 2004; N 11: С. 25 - 32.